Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
05/19/2017 05/23/2017 05/24/2017 05/25/2017 05/26/2017 Date
5.68 5.65 5.63 5.5 5.82 Last
25406 4230 1300 7180 9900 Volume
-0.70% -0.53% -0.35% -2.31% +5.82% Change
Financials ( CAD)
Sales 2017 40,2 M
EBIT 2017 -22,8 M
Net income 2017 -26,3 M
Debt 2017 -
Yield 2017 -
Sales 2018 67,3 M
EBIT 2018 2,89 M
Net income 2018 -7,68 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 4,62x
Capi. / Sales2018 2,76x
Capitalization 186 M
More Financials
Company
Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products.It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.It offers the Brinavess and Aggrastat... 
Sector
Pharmaceuticals
Calendar
08/15Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
05/16 CARDIOME PHARMA : Reports Changes To Senior Management Team
05/15 CARDIOME PHARMA : Reports First Quarter 2017 Financial Results
05/15 CARDIOME PHARMA CORP : Investor Network: Cardiome Pharma Corp. to Host Earnings ..
05/15 CARDIOME PHARMA : Announces Amendment to Term Loan Agreement with CRG-Managed Fu..
05/08 CARDIOME PHARMA : To Hold First Quarter 2017 Financial Results Conference Call O..
04/27 CARDIOME PHARMA : to Present at the Bloom Burton & Co. 6th Annual Healthcare Inv..
04/26 CARDIOME PHARMA CORP : Research Reports Initiated on Healthcare Stocks: Cardiome..
04/06 CARDIOME PHARMA : Partner SteadyMed Announces Successful Completion of TREVYENT®..
04/06 CARDIOME PHARMA : Partner SteadyMed Announces Successful Completion of Trevyent®..
04/03 CARDIOME PHARMA : Partner SteadyMed Receives Favourable Ruling In Its USPTO Inte..
More news
Sector news : Biopharmaceuticals
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/25 CARDIOME PHARMA : The Pieces Are Coming Together
05/16 Cardiome announces changes to executive team
05/15 Cardiome Pharma's (CRME) CEO Bill Hunter on Q1 2017 Results - Earnings Call T..
05/15 Cardiome Pharma misses by $0.05, misses on revenue
05/15 Cardiome amends loan agreement, $50M available to borrow
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 11,3  CAD
Spread / Average Target 94%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
William L. Hunter President, Chief Executive Officer & Director
William James O'Shea Chairman
Sheila M. Grant Chief Operating Officer
Justin A. Renz Chief Financial Officer
Richard M. Glickman Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP46.97%138
BIOGEN INC-4.03%53 198
CSL LIMITED31.73%44 709
ALEXION PHARMACEUTICAL..-20.15%21 939
GRIFOLS SA31.81%17 451
BIOMARIN PHARMACEUTICA..6.23%15 355
More Results